Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$11.38 - $19.03 $63,716 - $106,548
-5,599 Reduced 35.16%
10,324 $189,000
Q4 2023

Feb 12, 2024

SELL
$6.29 - $15.72 $131,398 - $328,390
-20,890 Reduced 56.75%
15,923 $195,000
Q3 2023

Nov 13, 2023

BUY
$14.99 - $32.65 $453,807 - $988,446
30,274 Added 462.98%
36,813 $551,000
Q2 2023

Aug 14, 2023

BUY
$29.76 - $46.14 $194,600 - $301,709
6,539 New
6,539 $212,000
Q3 2022

Nov 14, 2022

SELL
$36.98 - $49.2 $702 - $934
-19 Reduced 0.14%
13,821 $622,000
Q2 2022

Aug 15, 2022

BUY
$28.03 - $45.8 $15,416 - $25,190
550 Added 4.14%
13,840 $504,000
Q1 2022

May 13, 2022

SELL
$29.24 - $44.06 $4,386 - $6,609
-150 Reduced 1.12%
13,290 $549,000
Q4 2021

Feb 14, 2022

SELL
$39.32 - $61.61 $246,497 - $386,233
-6,269 Reduced 31.81%
13,440 $573,000
Q3 2021

Nov 15, 2021

SELL
$44.0 - $65.8 $440,352 - $658,526
-10,008 Reduced 33.68%
19,709 $1.09 Million
Q2 2021

Aug 13, 2021

BUY
$44.66 - $63.06 $96,778 - $136,651
2,167 Added 7.87%
29,717 $1.42 Million
Q1 2021

May 14, 2021

BUY
$46.31 - $62.7 $74,420 - $100,758
1,607 Added 6.19%
27,550 $1.4 Million
Q4 2020

Feb 12, 2021

SELL
$55.51 - $69.94 $21,759 - $27,416
-392 Reduced 1.49%
25,943 $1.63 Million
Q3 2020

Nov 16, 2020

BUY
$42.19 - $69.61 $474,890 - $783,530
11,256 Added 74.65%
26,335 $1.77 Million
Q2 2020

Aug 14, 2020

BUY
$27.55 - $43.28 $136,455 - $214,365
4,953 Added 48.91%
15,079 $632,000
Q1 2020

May 14, 2020

SELL
$23.16 - $47.8 $943,214 - $1.95 Million
-40,726 Reduced 80.09%
10,126 $319,000
Q4 2019

Feb 13, 2020

BUY
$27.97 - $40.38 $1.42 Million - $2.05 Million
50,852 New
50,852 $2.05 Million

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.